American Liver Society


American Liver Society


Donate Life

         Liver Society

   Liver Health

   Liver Diseases

   Liver Disorders

   Liver Syndromes

     Liver Transplants

Viral Hepatitis C

What are the effects of coinfection on disease progression of HCV and HIV?

Chronic HCV infection develops in 75%-85% of infected persons and leads to chronic liver disease in 70% of these chronically infected persons. HIV-HCV coinfection has been associated with higher titers of HCV, more rapid progression to HCV-related liver disease, and an increased risk for HCV-related cirrhosis (scarring) of the liver. Because of this, HCV infection has been viewed as an opportunistic infection in HIV-infected persons and was included in the 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. It is not, however, considered an AIDS-defining illness. As highly active antiretroviral therapy (HAART) and prophylaxis of opportunistic infections increase the life span of persons living with HIV, HCV-related liver disease has become a major cause of hospital admissions and deaths among HIV-infected persons.

The effects of HCV coinfection on HIV disease progression are less certain. Some studies have suggested that infection with certain HCV genotypes is associated with more rapid progression to AIDS or death. However, the subject remains controversial. Since coinfected patients are living longer on HAART, more data are needed to determine if HCV infection influences the long-term natural history of HIV infection.

About the American Liver Society

American Liver Society Groups

American Liver Society Advocay

American Liver Society Resources

American Liver Society Research

American Liver Society Legal

         About Us






Web site design by: Global Advanced Media

Web site hosting courtesy of Global Advanced Media